Skip to main content
UniHealth

Doctor search

Jessica June Walter, MD

Neurology · Stanford

NPI 1518281161

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Offices
4

Offices

4 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Walter’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A145067 · Current

Licensed to practise in California · since 2016 · expires 2027-10-31 · Georgetown University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$65,986

Medicare paid this office $65,986 for 323 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional68$22,909$185
Long return visit (40+ min)88$13,589$122
Long return visit (40+ min)48$9,093$149
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional28$3,266$117
Return visit (30+ min)22$2,578$107
See all 11 services
Every Original Medicare service billed
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional68$22,909$185
Long return visit (40+ min)88$13,589$122
Long return visit (40+ min)48$9,093$149
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional28$3,266$117
Return visit (30+ min)22$2,578$107
New patient visit (60+ min)16$2,365$148
Return visit (30+ min)26$1,878$72
Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report17$1,619$95
Measurement of brain wave activity (eeg), 61-119 minutes13$1,016$78
Measurement of brain wave activity (eeg), awake and asleep19$927$49
Measurement of brain wave activity (eeg), awake and drowsy16$825$49

Who their Medicare patients are

323 Original Medicare patients in 2024. Average age 68 · Under 65 28% · 85 and older 11% · Women 51% · Also on Medicaid 44% · Health risk score 2.01. Above the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 64% · Diabetes 33% · Stroke 32% · Depression 31% · Chronic kidney disease 29% · Coronary heart disease 28% · Dementia 24% · Heart failure 20% · Atrial fibrillation 20% · COPD 14% · Cancer 12%.

The office billed $500,193, Medicare allowed $87,958 and paid $65,986; for 540 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024323540682.01$500,193$65,986
2023353631671.73$930,961$73,344
2022208345661.68$623,034$41,765
2021307575671.63$1,073,209$70,531
2020299546641.73$842,097$52,968
2019342632641.64$240,002$83,081
2018220384701.72$141,190$54,111
2017257405711.68$135,142$50,704
20162122741.40$8,429$2,769

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Original Medicare services billed in 2023
Long return visit (40+ min)150$24,291$112
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional80$23,755$187
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional27$3,325$119
New patient visit (60+ min)20$3,173$159
Return visit (30+ min)34$2,891$85
Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report20$1,871$94
Measurement of brain wave activity (eeg), awake and asleep18$954$53
Measurement of brain wave activity (eeg), awake and drowsy13$636$49
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or12$609$26

2022: 5 services

Original Medicare services billed in 2022
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional41$14,281$190
Long return visit (40+ min)93$13,921$113
Return visit (30+ min)26$2,273$78
New patient visit (60+ min)14$2,176$155
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional14$1,733$124

2021: 8 services

Original Medicare services billed in 2021
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional74$25,945$194
Long return visit (40+ min)122$21,110$115
New patient visit (60+ min)24$3,888$162
Return visit (30+ min)35$2,931$79
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional23$2,890$126
New patient visit (45+ min)13$1,675$129
Short return visit (20+ min)17$849$50
New patient visit (30+ min)11$777$71

2020: 10 services

Original Medicare services billed in 2020
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional55$20,866$195
Long return visit (40+ min)68$6,222$79
Return visit (30+ min)81$5,800$59
New patient visit (60+ min)19$2,486$131
Measurement of brain wave activity (eeg), awake and asleep21$1,164$55
New patient visit (45+ min)12$1,127$94
Telephone medical discussion with physician, 21-30 minutes14$962$69
Long return visit (40+ min)11$859$78
Return visit (30+ min)11$575$52
Short return visit (20+ min)14$429$31

2019: 7 services

Original Medicare services billed in 2019
Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG)54$38,104$298
Long return visit (40+ min)144$17,569$84
New patient visit (60+ min)44$6,506$148
Monitoring and localization of seizure activity over 24-hour period using portable 16-channel electroencephalograph (EEG)15$5,857$150
Return visit (30+ min)72$5,164$63
New patient visit (45+ min)11$1,166$106
Measurement of brain wave activity (eeg), awake and asleep13$702$54

2018: 7 services

Original Medicare services billed in 2018
Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG)41$25,051$291
Long return visit (40+ min)68$7,627$90
New patient visit (60+ min)56$6,392$114
Monitoring and localization of seizure activity over 24-hour period using portable 16-channel electroencephalograph (EEG)13$4,538$146
Long return visit (40+ min)16$1,596$100
Return visit (30+ min)18$1,130$59
Measurement of brain wave activity (eeg), awake and asleep12$585$49

2017: 4 services

Original Medicare services billed in 2017
New patient visit (60+ min)172$23,205$135
Long return visit (40+ min)104$14,304$99
Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG)11$7,916$293
Return visit (30+ min)13$988$71

2016: 1 service

Original Medicare services billed in 2016
New patient visit (60+ min)12$1,762$147

Medicaid work

$17,858 in 2024

Medicaid paid $17,858 for 157 billed services this clinician did in 2024, up to 19 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG)77$13,084
Long return visit (40+ min)80$4,774
Medicaid work by year
2024157219$17,858
2023276230$14,416
2022137130$5,728
2021225228$16,375
2020146318$8,641
2019192224$8,097
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)249$11,470
Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG)27$2,946

2022

Largest Medicaid services in 2022
Long return visit (40+ min)137$5,728

2021

Largest Medicaid services in 2021
Long return visit (40+ min)178$8,477
Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG)47$7,897

2020

Largest Medicaid services in 2020
Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG)24$4,675
Return visit (30+ min)90$2,647
Long return visit (40+ min)32$1,319

2019

Largest Medicaid services in 2019
Long return visit (40+ min)167$7,435
Return visit (30+ min)25$662

Drugs they prescribed that Part D paid

$1,286,720

Pharmacies billed $1,286,720 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,923) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

2,333 generic and 558 brand-name prescriptions · $1,286,720 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xcopri165$252,571$1,531
Vimpat60$114,198$1,903
Keppra54$109,749$2,032
Briviact42$66,101$1,574
Nayzilam53$64,383$1,215
See all 41 drugs
Every Part D drug this clinician prescribed
Xcopri165$252,571$1,531
Vimpat60$114,198$1,903
Keppra54$109,749$2,032
Briviact42$66,101$1,574
Nayzilam53$64,383$1,215
Rufinamide50$57,818$1,156
Lamictal36$57,196$1,589
Fycompa21$52,747$2,512
Lacosamide241$48,516$201
Clobazam140$29,703$212
Valtoco16$21,081$1,318
Levetiracetam303$18,549$61
Depakote Er13$14,639$1,126
Carbamazepine Er86$9,448$110
Lamotrigine Er60$8,348$139
Neurontin12$7,746$646
Divalproex Sodium Er102$6,990$69
Divalproex96$6,435$67
Lamotrigine314$6,391$20
Oxcarbazepine86$6,113$71
Zyprexa12$4,789$399
Dilantin23$2,994$130
Carbamazepine19$2,947$155
Gabapentin62$2,836$46
Levetiracetam Er22$2,622$119
Tegretol11$1,925$175
Topiramate84$1,879$22
Diazepam11$1,740$158
Pregabalin61$1,705$28
Levocarnitine29$1,657$57
Phenobarbital32$1,400$44
Clonazepam164$1,118$7
Phenytoin Sodium Extended25$1,105$44
Primidone17$1,079$63
Clorazepate Dipotassium11$1,051$96
Phenytoin16$614$38
Lorazepam98$438$4
Zonisamide30$326$11
Escitalopram35$256$7
Sertraline35$217$6
Mirtazapine12$51$4

Year by year

Part D prescribing by year
20242,9231980% (0)19%$1,286,720
20232,9122200% (0)22%$1,626,009
20221,8231870% (0)25%$1,167,480
20212,6041960% (0)26%$1,461,844
20202,658212None24%$1,260,691
20192,4182030% (0)25%$1,087,679
2018429810% (0)None$72,864
201734593None9%$25,166
201414None0% (0)0%$426

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 44 drugs

Part D drugs prescribed in 2023
Xcopri147$192,935$1,312
Lamictal35$182,222$5,206
Banzel24$135,498$5,646
Keppra69$118,181$1,713
Vimpat53$90,692$1,711
Rufinamide53$87,459$1,650
Briviact46$79,147$1,721
Lacosamide204$74,366$365
Aptiom15$67,883$4,526
Nayzilam68$61,332$902
Fycompa19$41,408$2,179
Clobazam130$26,877$207
Levetiracetam326$23,858$73
Lamotrigine312$15,932$51
Valtoco14$14,957$1,068
Depakote Er17$14,418$848
Lamotrigine Er48$12,110$252
Neurontin15$9,227$615
Carbamazepine Er71$9,076$128
Divalproex Sodium Er80$7,784$97
Divalproex79$6,711$85
Oxcarbazepine66$5,785$88
Dilantin27$5,331$197
Zyprexa13$5,188$399
Phenytoin16$3,136$196
Pregabalin48$3,035$63
Topiramate60$2,792$47
Clonazepam180$2,562$14
Phenobarbital34$2,528$74
Carbamazepine18$2,277$126
Gabapentin75$2,263$30
Primidone33$2,114$64
Tegretol11$2,089$190
Levetiracetam Er15$1,572$105
Levocarnitine19$1,563$82
Phenytoin Sodium Extended24$947$39
Lorazepam108$939$9
Sertraline53$674$13
Escitalopram32$567$18
Propranolol Hcl Er11$477$43
Zonisamide21$425$20
Risperidone12$245$20
Propranolol11$163$15
Mirtazapine13$54$4

2022: 41 drugs

Part D drugs prescribed in 2022
Lamictal18$172,745$9,597
Banzel27$117,660$4,358
Vimpat80$116,006$1,450
Epidiolex18$85,494$4,750
Keppra42$78,437$1,868
Rufinamide46$74,303$1,615
Xcopri56$55,518$991
Briviact30$37,991$1,266
Clobazam74$31,097$420
Aptiom11$28,408$2,583
Fycompa20$25,623$1,281
Nayzilam18$24,325$1,351
Lacosamide58$21,262$367
Levetiracetam201$19,898$99
Onfi11$17,732$1,612
Depakote Er26$16,142$621
Oxtellar Xr11$14,573$1,325
Neurontin13$7,447$573
Carbamazepine Er35$6,398$183
Divalproex Sodium Er57$6,195$109
Lamotrigine Er25$5,935$237
Zyprexa15$5,503$367
Oxcarbazepine57$5,345$94
Lamotrigine177$5,141$29
Divalproex46$4,090$89
Dilantin22$3,801$173
Carbamazepine16$2,892$181
Tegretol12$2,776$231
Pregabalin30$2,505$84
Clonazepam111$1,380$12
Topiramate40$1,194$30
Phenytoin Sodium Extended30$1,133$38
Gabapentin29$1,109$38
Levocarnitine11$841$76
Phenobarbital19$707$37
Lorazepam72$556$8
Primidone23$474$21
Sertraline21$419$20
Donepezil17$257$15
Sumatriptan14$116$8
Escitalopram20$107$5

2021: 47 drugs

Part D drugs prescribed in 2021
Banzel64$325,251$5,082
Vimpat216$245,204$1,135
Lamictal26$124,137$4,774
Rufinamide48$80,174$1,670
Keppra50$73,986$1,480
Aptiom13$63,175$4,860
Xcopri50$55,601$1,112
Onfi20$31,412$1,571
Briviact22$25,749$1,170
Fycompa21$25,454$1,212
Levetiracetam310$24,386$79
Valtoco12$18,625$1,552
Nayzilam19$16,059$845
Depakote Er14$12,605$900
Clobazam115$11,684$102
Depakote11$10,727$975
Divalproex90$9,623$107
Divalproex Sodium Er66$8,454$128
Neurontin15$8,277$552
Lamotrigine Er24$7,783$324
Lamotrigine288$7,699$27
Carbamazepine Er40$6,523$163
Oxcarbazepine80$6,494$81
Carbamazepine30$6,260$209
Zyprexa15$5,659$377
Pregabalin58$4,723$81
Dilantin23$4,694$204
Levetiracetam Er18$4,509$250
Memantine25$4,228$169
Tegretol12$2,895$241
Carbatrol13$2,830$218
Clonazepam198$2,003$10
Propranolol Hcl Er20$1,778$89
Topiramate59$1,767$30
Atomoxetine14$1,619$116
Gabapentin58$1,471$25
Phenytoin Sodium Extended43$1,424$33
Primidone26$1,080$42
Phenobarbital28$934$33
Lorazepam71$651$9
Sertraline34$459$13
Venlafaxine Hcl Er12$441$37
Propranolol11$350$32
Carbidopa-Levodopa14$289$21
Olanzapine12$188$16
Escitalopram18$139$8
Sumatriptan12$67$6

2020: 42 drugs

Part D drugs prescribed in 2020
Banzel95$420,930$4,431
Vimpat133$153,830$1,157
Keppra46$67,769$1,473
Onfi40$63,833$1,596
Lamictal42$61,267$1,459
Fycompa57$57,305$1,005
Aptiom11$42,154$3,832
Briviact21$25,735$1,225
Depakote Er24$23,095$962
Neurontin32$18,565$580
Levetiracetam307$16,712$54
Lamotrigine Er32$14,297$447
Clobazam108$12,943$120
Xcopri13$12,195$938
Lamotrigine287$8,017$28
Carbamazepine Er27$6,220$230
Dilantin23$5,996$261
Zyprexa19$5,858$308
Divalproex87$5,809$67
Carbamazepine33$5,688$172
Divalproex Sodium Er71$5,519$78
Pregabalin73$5,481$75
Oxcarbazepine73$5,070$69
Carbatrol20$4,347$217
Levetiracetam Er18$2,806$156
Gabapentin102$2,461$24
Clonazepam197$2,387$12
Topiramate79$2,107$27
Propranolol Hcl Er20$1,616$81
Phenobarbital36$1,279$36
Phenytoin Sodium Extended23$1,203$52
Zolpidem Tartrate Er12$1,065$89
Lorazepam118$944$8
Primidone20$851$43
Donepezil25$615$25
Nefazodone12$515$43
Risperidone29$444$15
Propranolol12$430$36
Escitalopram22$311$14
Lorazepam Intensol12$260$22
Memantine12$224$19
Sertraline19$119$6

2019: 46 drugs

Part D drugs prescribed in 2019
Banzel96$386,256$4,024
Vimpat80$97,249$1,216
Onfi49$85,529$1,745
Lamictal40$71,548$1,789
Fycompa56$64,653$1,155
Keppra39$59,456$1,525
Trileptal12$23,171$1,931
Lyrica42$23,052$549
Clobazam59$16,898$286
Levetiracetam266$12,123$46
Lamotrigine Er25$11,473$459
Neurontin19$10,801$568
Depakote Er11$9,319$847
Carbamazepine Er54$7,319$136
Lamotrigine248$5,899$24
Dilantin31$5,152$166
Divalproex Sodium Er55$4,988$91
Zyprexa13$4,648$358
Divalproex77$3,626$47
Oxcarbazepine64$3,566$56
Pregabalin23$3,499$152
Carbatrol23$2,937$128
Atomoxetine13$2,538$195
Gabapentin81$2,414$30
Phenobarbital41$2,290$56
Carbamazepine27$2,289$85
Levetiracetam Er22$2,053$93
Phenytoin Sodium Extended38$1,387$37
Memantine24$1,306$54
Topiramate92$1,159$13
Propranolol Hcl Er17$980$58
Clonazepam153$968$6
Potassium Citrate Er11$906$82
Donepezil43$883$21
Zonisamide18$687$38
Duloxetine25$506$20
Lorazepam117$485$4
Lorazepam Intensol13$449$35
Propranolol18$390$22
Primidone12$372$31
Carbidopa-Levodopa19$357$19
Amitriptyline13$285$22
Sertraline30$178$6
Risperidone20$173$9
Citalopram Hbr19$95$5
Furosemide11$29$3

2018: 10 drugs

Part D drugs prescribed in 2018
Levetiracetam58$3,497$60
Memantine31$1,730$56
Topiramate18$1,200$67
Donepezil58$979$17
Gabapentin33$809$25
Duloxetine14$471$34
Lamotrigine27$365$14
Carbidopa-Levodopa16$318$20
Propranolol21$159$8
Lorazepam17$42$2

2017: 9 drugs

Part D drugs prescribed in 2017
Levetiracetam48$1,410$29
Donepezil58$544$9
Topiramate13$472$36
Gabapentin24$349$15
Lamotrigine19$295$16
Duloxetine15$256$17
Nortriptyline21$204$10
Carbidopa-Levodopa14$178$13
Amitriptyline17$144$8

Money from drug and device companies

$132 in 2025

Industry payments by year
202511None$132
202411None$13
202011None$12

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
SK Life ScienceNone$132
1 payment
  • Meals · 2025-12-05 · $132
See the published payment
Every published payment
SK Life ScienceMeals · 2025-12-05None$132
See earlier years (2024, 2020)

2024: $13

Payments by company in 2024
NeurelisValtoco$13
1 payment
  • Education for Valtoco · 2024-02-26 · $13

2020: $12

Payments by company in 2020
SK Life ScienceCenobamate$12
1 payment
  • Education for Cenobamate · 2020-10-27 · $12

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1518281161
Licence
CA A145067California A145067: Current · expires 2027-10-31
Trained
Georgetown University School of Medicine, 2010
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 2084E0001X (2084E0001X); Neurology (2084N0400X); Federal specialty code 2084N0600X (2084N0600X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2010-03-24
NPI last updated
2023-11-09
NPI record certified
2023-11-09

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 213 Quarry Rd Fl 4, Palo Alto, CA, 94304